Washington Golf & Country Club 3017 N. Glebe Road Arlington, VA 22207
What are "Governing Principles"? Where do they come from? Why do "principles" matter?
How many Boards today operate under a set of "Governing Principles"? If "governing principles" frameworks are not in place - beyond charters - do Boards simply "wing it"? One seasoned, nationally-recognized board member recently said "model board members focus on three key "C" principles to guide their work: courage, competency, and character. " What about transparency? Independence? Information availability? Written "standards for excellence?"NACD's seminal work - "Key Agreed Principles to Strengthen Corporate Governance" - provides a strategic framework, BUT, boardroom masters of governance excellence fully agree "No One Size Fits All".
Join us for a highly-interactive & compelling session on governing principles by our distinguished panelist. Fill your tool bag with the takeaways & action items for driving excellence in boardroom leadership. This is a "must attend" session.
What governing principles really are, are not, and why standards matter.
If "No One Size Fits All" is correct, how do you determine what "yours" are?
What are the leading practices and Board processes to achieve standards for excellence? Are these living, changing & needing frequent updating and refining?
The early warning signals of looming problems, and what boards need to do.
Secrets of high-performing boards in avoiding pit-falls & techniques for self-correction.
Situations / cases where NOT following agreed upon principles might be prudent.
Joyce Cacho, CAMS, an experienced board director, brings strength in cybersecurity where her technology and brand-building expertise links software as a service
(SaaS) to compliance, company performance, resiliency, and cultural and digital competencies. Knowledge of financial operations, including ESG intersection with the supply chain, data integrity/blockchain, and the relationship to M&A trends is another of Joyce’s strengths.
Cacho is a board director of Land O’Lakes, Inc. — a Fortune 200 company, and Sunrise Banks, with a grow ing fintech/payments division. Committee experience includes finance & audit; compliance & Bank Secrecy Act; operating; and governance. Manufacturing, CPG, and innovation technology industries also inform Land O’Lakes, Inc., and Sunrise Banks. Distribution and services industries and REITs are ongoing interests. Cacho is a member of CFA-NY and a NACD board leadership fellow.
Raymond V. Gilmartin is the former Chairman, President and Chief Executive Officer of Merck & Co., Inc., a global research driven pharmaceutical company that discovers, develops, manufactures and markets innovative vaccines and medicines. Mr. Gilmartin joined Merck as President and Chief Executive Officer in June 1994 and was named to the additional position of Chairman of the Board in November 1994. Shortly after retiring from Merck in 2006, he joined the faculty at Harvard Business School where he taught in the MBA and executive education programs through 2012. Prior to joining Merck, Mr. Gilmartin served as Chairman, President and CEO of Becton Dickinson, a global company that develops, manufactures and markets medical devices and diagnostic products. He joined that company in 1976 as vice president, strategic planning, and took on positions of increasing responsibility over the next eighteen years.
Mr. Gilmartin is on the board of the National Association of Corporate Directors. He has served as the Lead Director for Microsoft and General Mills. He is a trustee of the Committee for Economic Development. He is the past Chairman of the Board of The United Negro College Fund and has served as Chairman of the Board of Dean's Advisors for the Harvard Business School.
Mr. Gilmartin has been an active participant in health industry affairs worldwide. Mr. Gilmartin was co-chair of the Presidential Advisory Council on HIV/AIDS, is a past chair of the Healthcare Leadership Council and was a board member of the Alliance for Healthcare Reform. In addition, he is the past chair of the Pharmaceutical Research and Manufacturers of America and a past president of the International Federation of the Pharmaceutical Manufacturers Associations. Mr. Gilmartin also has been involved in global economic and trade issues that concern the pharmaceutical industry. He was a member of the President's Export Council and is a past chair of the Council on Competitiveness. Mr. Gilmartin received a BS in electrical engineering from Union College in 1963 and an MBA from Harvard Business School in 1968.